
Ventricular Assist Device Developer and Manufacturer

Recently, internationally renowned artificial heart clinical expert and former president of the American Society for Artificial Internal OrgansProfessor James W. LongVisited BrioHealth Solutions and conducted multiple academic exchange activities on artificial hearts in China. The relevant person in charge of the company received Professor James W. Long, achieving positive results.
Professor James W. LongFirstUnderstoodProgress of BrioHealth Solutions in China in the promotion of artificial heart projects, professional education, clinical services, quality control, and medical research.Mr. Lu Chengjie, President of China Region of BrioHealth Solutions, gave a detailed introduction to Professor James W. Long.The Development Process of the Chinese Market, andHow to Promote the Development of Multidisciplinary Collaboration in China's Artificial Heart Field and Ensure Long-Term High-Quality Life for PatientsProfessor James W. Long spoke highly of the company's achievements in China.

Professor James W. Long Visits BrioHealth Solutions' China Commercial Headquarters
Subsequently, Professor James W. Long shared with the company's clinical, medical, marketing, and R&D teams the experiences and lessons learned from over 30 years of artificial heart projects and therapy development in the United States, summarizing...The success of the artificial heart project in the United States is mainly due to multiple factors such as technological advancements, patient selection, patient management, and organizational management.The impact; at the same time, it introduces in detail the specific work carried out by the U.S. artificial heart program in multidisciplinary cooperation and long-term patient management, andEmphasizeThe team must focus on quality to achieve more substantial development in promoting the artificial heart project in China.Finally, the company team and Professor James W. Long conducted further detailed discussions on specific issues such as therapy promotion, surgical techniques, R&D improvements, and related fundamental research.


Professor James W. Long Shares Experience on the Development of Artificial Hearts in the United States

Professor James W. Long and the company team engage in in-depth exchanges
During his visit to China this time, Professor James W. Long also visited several domestic hospitals that are currently undertaking artificial heart projects. He conducted extensive academic exchanges with Chinese experts on issues such as surgical techniques, clinical management, and therapy development, sharing a wealth of experiences and lessons regarding artificial hearts in the international community.
Since its commercialization, BrioHealth Solutions has been committed to advancing the development of artificial heart therapies in China by introducing internationally advanced heart failure treatment concepts. It adheres to providing professional education and comprehensive services that meet international standards, focusing on patients' long-term high-quality life. To this end, the company has built an extensive international exchange platform. The visit of Professor James W. Long to BrioHealth Solutions and his participation in related academic activities represent a significant step for the company in promoting international exchanges, fostering international cooperation, and building an international brand.
Introduction to Professor James W. Long
Professor James W. Long is an internationally renowned clinical expert in artificial hearts and has served as the president of the American Society for Artificial Internal Organs. He has led or participated in several significant clinical trials in the U.S. artificial heart field and played a key role in the landmark REMATCH Trial, which facilitated the approval of artificial hearts for long-term indications in the United States, leading to their widespread application. Meanwhile, he has consistently been a leader in improving clinical outcomes, enhancing quality of life, and reducing treatment costs in the international artificial heart field. He established and directed multiple artificial heart programs in Utah, Oklahoma, and other regions in the U.S., elevating these programs to globally leading standards.
